MMedication Read More Can Ozempic Help People Recover From Substance Addiction?7 May 2025 You’re probably all too familiar with Ozempic and other diabetes medications that are commonly used as weight-loss drugs.…
MMental health Read More Ads, sports and games: how gambling infiltrated Australian culture4 May 2025 If you’re watching sport or browsing social media, odds are you will come across gambling ads. If you…
HHealth Read More Ketamine’s Hidden Physical and Psychological Damage29 April 2025 Summary: A new study highlights the severe physical and psychological consequences linked to ketamine addiction, with many users…
MMental health Read More Substance-Induced vs Primary Psychosis: Are They Different?26 April 2025 MADRID — Recent research on the progression and treatment of psychosis is prompting some experts to ask: Are…
MMedication Read More California launches $24 naloxone accessible to state residents online – The Mercury News24 April 2025 Californians now have affordable access to naloxone, a medication that can reverse overdoses, through a state program aimed…
UUK Read More Vaping trends shift as UK ban drives switch from disposable to reusable devices21 April 2025 A nationwide shift is underway as Britain’s looming disposable vape ban halts the upward trend in e-cigarette use.…
GGenetics Read More GLP1 agonists linked to depression risk in new genetic study18 April 2025 A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely…
MMedication Read More Is This Opioid Algorithm Misleading Doctors, Hurting Patients?17 April 2025 This article is the first in a series on prescription drug monitoring programs and analysis tools designed to…
MMedication Read More What Else Can GLP-1 Drugs Do for Your Patients?12 April 2025 Glucagon-like peptide 1 (GLP-1) receptor agonists are transforming the treatment landscape for type 2 diabetes ( T2D) and…